Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Circulating Bcl-2/Igh Levels before and after Treatment in 415 Patients with Advanced Follicular Lymphoma Receiving First-Line Immuno-Chemotherapy in 2 Prospective StiL Trials - the Effect of Rituximab Maintenance

Guido Kobbe, Sabrina Pechtel, Fabian Zohren, MD PhD, Jürgen Barth, Alexander Christoph Burchardt, MD, Christian Buske, MD, Ariane Dienst, MD, Ulrich Germing, MD, Richard Greil, MD, Bernd Hertenstein, MD, Frank Kauff, Michael Koenigsmann, MD, Christian Lerchenmüller, MD, Thomas Michael Schroeder, MD PhD, Rainer Haas, MD, Mathias J Rummel, MD PhD

Blood (2018) 132 (Supplement 1): 4149.

https://doi.org/10.1182/blood-2018-99-118750

Published: 2018

Journal Articles

WT1 mRNA Expression in the Peripheral Blood of Patients with MDS Yields Additional Prognostic Information within the IPSS-R Risk Categories "Very Low", "Low" and "Intermediate"

Christina Rautenberg, MD, Sabrina Pechtel, Norbert Gattermann, MD, Rainer Haas, MD, Ulrich Germing, MD, Guido Kobbe, Thomas Michael Schroeder, MD PhD

Blood (2018) 132 (Supplement 1): 1827.

https://doi.org/10.1182/blood-2018-99-113524

Published: 2018

Journal Articles

Comparison Between Wilms' Tumor 1 (WT1) Expression Using a Standardized European Leukemia Net (ELN)-Certified Assay and Other Methods for Detection of Minimal Residual Disease (MRD) in MDS and AML Patients after Allogeneic Blood Stem Cell Transplantation

Christina Rautenberg, MD, Sabrina Pechtel, Barbara Hildebrandt, Beate Betz, Ariane Dienst, MD, Kathrin Nachtkamp, MD, Stefanie Geyh, Pia Verena Schmidt, MD, Claudia Heyn, MD, Mustafa Kondakci, MD, Norbert Gattermann, MD, Rainer Haas, MD, Ulrich Germing, Guido Kobbe, MD, Thomas Schroeder, MD

Blood (2016) 128 (22): 3447.

https://doi.org/10.1182/blood.V128.22.3447.3447

Published: 2016

Journal Articles

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Fabian Zohren, Ingmar Bruns, Sabrina Pechtel, Thomas Schroeder, Roland Fenk, Akos Czibere, Georg Maschmeyer, Dorothea Kofahl-Krause, Norbert Niederle, Gerhard Heil, Christoph Losem, Manfred Welslau, Wolfram Brugger, Ulrich Germing, Ralf Kronenwett, Juergen Barth, Mathias J. Rummel, Rainer Haas, Guido Kobbe

Blood (2015) 126 (12): 1407–1414.

https://doi.org/10.1182/blood-2015-03-630012

Published: 2015

Includes: Supplemental data

Journal Articles

Monitoring of Wilms’ Tumor 1 (WT1) Expression in Peripheral Blood (PB) of Patients with Myelodysplastic Syndromes (MDS) By a Standardized European Leukemia Net (ELN)-Certified Assay to Detect Minimal Residual Disease (MRD) and Guide Therapeutic Interventions Following Allogeneic Transplantation

Thomas Schroeder, MD, Sabrina Pechtel, Marius Lamers, Ariane Dienst, Esther Schuler, Elena Rachlis, MD, Nadija Wegener, Andrea Kündgen, Mustafa Kondakci, MD, Roland Fenk, MD, Norbert Gattermann, MD PhD, Rainer Haas, MD, Ulrich Germing, Guido Kobbe, MD

Blood (2014) 124 (21): 4661.

https://doi.org/10.1182/blood.V124.21.4661.4661

Published: 2014

Journal Articles

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Fabian Zohren, Ingmar Bruns, MD, PhD, Juergen Barth, Sabrina Pechtel, Roland Fenk, Thomas Schroeder, Akos G. Czibere, MD, Georg Maschmeyer, Dorothea Kofahl-Krause, Gerhard Heil, Norbert Niederle, Christoph Losem, Manfred Welslau, Ulrich Germing, Ralf Kronenwett, Rainer Haas, Mathias J Rummel, MD, PhD, Guido Kobbe, MD

Blood (2009) 114 (22): 441.

https://doi.org/10.1182/blood.V114.22.441.441

Published: 2009

Journal Articles

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Daniela Bruennert, Akos Czibere, MD, PhD, Ingmar Bruns, MD, PhD, Sabrina Pechtel, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas, Neumann Frank

Blood (2008) 112 (11): 3231.

https://doi.org/10.1182/blood.V112.11.3231.3231

Published: 2008

Journal Articles

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Ingmar Bruns, MD, Akos G. Czibere, MD, Johannes C. Fischer, MD, Ulrich Steidl, MD, PhD, Sabrina Pechtel, Annemarie Koch, Daniela Brünnert, Sebastian Büst, Ron-Patrick Cadeddu, Ralf Kronenwett, MD, Rainer Haas, MD

Blood (2007) 110 (11): 3170.

https://doi.org/10.1182/blood.V110.11.3170.3170

Published: 2007

Journal Articles

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Johannes C. Fischer, MD, Sascha Raschke, Guido Kobbe, PhD, Roland Fenk, MD, Michael Rosskopf, Sabrina Pechtel, Ulrich-Peter Rohr, PhD, Arndt von Haeseler, PhD, Peter Wernet, PhD, Daniel Tenen, PhD, Rainer Haas, PhD, Ralf Kronenwett, PhD

Blood (2006) 108 (11): 3382.

https://doi.org/10.1182/blood.V108.11.3382.3382

Published: 2006

Journal Articles

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Guido Kobbe, MD, Roland Fenk, MD, Slawomir Kliszewski, Sabrina Pechtel, Rainer Haas, MD, PhD, Ralf Kronenwett, MD, PhD

Blood (2005) 106 (11): 5191.

https://doi.org/10.1182/blood.V106.11.5191.5191

Published: 2005

NARROW

Prognostic Value of Circulating Bcl-2/Igh Levels before and after Treatment in 415 Patients with Advanced Follicular Lymphoma Receiving First-Line Immuno-Chemotherapy in 2 Prospective StiL Trials - the Effect of Rituximab Maintenance

WT1 mRNA Expression in the Peripheral Blood of Patients with MDS Yields Additional Prognostic Information within the IPSS-R Risk Categories "Very Low", "Low" and "Intermediate"

Comparison Between Wilms' Tumor 1 (WT1) Expression Using a Standardized European Leukemia Net (ELN)-Certified Assay and Other Methods for Detection of Minimal Residual Disease (MRD) in MDS and AML Patients after Allogeneic Blood Stem Cell Transplantation

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Monitoring of Wilms’ Tumor 1 (WT1) Expression in Peripheral Blood (PB) of Patients with Myelodysplastic Syndromes (MDS) By a Standardized European Leukemia Net (ELN)-Certified Assay to Detect Minimal Residual Disease (MRD) and Guide Therapeutic Interventions Following Allogeneic Transplantation

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only